Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.

Wadas TJ, Eiblmaier M, Zheleznyak A, Sherman CD, Ferdani R, Liang K, Achilefu S, Anderson CJ.

J Nucl Med. 2008 Nov;49(11):1819-27. doi: 10.2967/jnumed.108.054502. Epub 2008 Oct 16.

PMID:
18927338
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.

Ginj M, Zhang H, Waser B, Cescato R, Wild D, Wang X, Erchegyi J, Rivier J, Mäcke HR, Reubi JC.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16436-41. Epub 2006 Oct 20.

PMID:
17056720
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, O'dorisio TM, Valkema R, Bodei L, Chinol M, Maecke HR, Krenning EP.

J Nucl Med. 2005 Jan;46 Suppl 1:62S-6S. Review.

PMID:
15653653
[PubMed - indexed for MEDLINE]
Free Article
5.

Somatostatin receptor subtypes: basic pharmacology and tissue distribution.

Corleto VD, Nasoni S, Panzuto F, Cassetta S, Delle Fave G.

Dig Liver Dis. 2004 Feb;36 Suppl 1:S8-16. Review.

PMID:
15077906
[PubMed - indexed for MEDLINE]
6.

Opportunities in somatostatin research: biological, chemical and therapeutic aspects.

Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C.

Nat Rev Drug Discov. 2003 Dec;2(12):999-1017. Review. No abstract available. Erratum in: Nat Rev Drug Discov. 2005 Dec;4(12):975.

PMID:
14654798
[PubMed - indexed for MEDLINE]
7.

Somatostatin receptors.

Møller LN, Stidsen CE, Hartmann B, Holst JJ.

Biochim Biophys Acta. 2003 Sep 22;1616(1):1-84. Review.

PMID:
14507421
[PubMed - indexed for MEDLINE]
Free Article
8.

Somatostatin and somatostatin receptor physiology.

Barnett P.

Endocrine. 2003 Apr;20(3):255-64. Review.

PMID:
12721505
[PubMed - indexed for MEDLINE]
9.

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.

Reubi JC, Schär JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Mäcke HR.

Eur J Nucl Med. 2000 Mar;27(3):273-82.

PMID:
10774879
[PubMed - indexed for MEDLINE]
10.

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC, et al.

Eur J Nucl Med. 1993 Aug;20(8):716-31. Review.

PMID:
8404961
[PubMed - indexed for MEDLINE]
11.

In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the rat.

Patel YC, Wheatley T.

Endocrinology. 1983 Jan;112(1):220-5. No abstract available.

PMID:
6128222
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk